 | Up a level |
Windecker, Stephan; Lopes, Renato D; Massaro, Tyler; Jones-Burton, Charlotte; Granger, Christopher B; Aronson, Ronald; Heizer, Gretchen; Goodman, Shaun G; Darius, Harald; Jones, W Schuyler; Aschermann, Michael; Brieger, David; Cura, Fernando; Engstrøm, Thomas; Fridrich, Viliam; Halvorsen, Sigrun; Huber, Kurt; Kang, Hyun-Jae; Leiva-Pons, Jose L; Lewis, Basil S; ... (2019). Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial. Circulation, 140(23), pp. 1921-1932. American Heart Association 10.1161/CIRCULATIONAHA.119.043308
Lip, Gregory Y H; Windecker, Stephan; Huber, Kurt; Kirchhof, Paulus; Marin, Francisco; Ten Berg, Jurriën M; Haeusler, Karl Georg; Boriani, Giuseppe; Capodanno, Davide; Gilard, Martine; Zeymer, Uwe; Lane, Deirdre; Storey, Robert F; Bueno, Hector; Collet, Jean-Philippe; Fauchier, Laurent; Halvorsen, Sigrun; Lettino, Maddalena; Morais, Joao; Mueller, Christian; ... (2014). Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). European Heart Journal, 35(45), pp. 3155-3179. Oxford University Press 10.1093/eurheartj/ehu298
